Reviva Pharmaceuticals Holdings, Inc.

GEODE CAPITAL MANAGEMENT, LLC RVPH

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/9/2026

Shares

1,048,954

Value ($000)

293

Weight

0.0%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/9/2026	293	0.0%	1,048,954	12/31/2025
2025 Q3	11/12/2025	206	0.0%	559,243	9/30/2025
2025 Q2	8/8/2025	171	0.0%	448,202	6/30/2025
2025 Q1	5/13/2025	400	0.0%	419,139	3/31/2025
2024 Q4	2/12/2025	564	0.0%	311,701	12/31/2024
2024 Q3	11/12/2024	401	0.0%	278,496	9/30/2024
2024 Q2	8/9/2024	302	0.0%	236,120	6/30/2024
2024 Q1	5/13/2024	832	0.0%	220,117	3/31/2024
2023 Q4	2/13/2024	921	0.0%	178,806	12/31/2023
2023 Q3	11/13/2023	836	0.0%	171,192	9/30/2023
2023 Q2	8/11/2023	885	0.0%	150,949	6/30/2023
2023 Q1	5/15/2023	609	0.0%	145,430	3/31/2023
2022 Q4	2/13/2023	618	0.0%	145,430	12/31/2022
2022 Q3	11/14/2022	124	0.0%	78,075	9/30/2022
2022 Q2	8/12/2022	88	0.0%	80,673	6/30/2022
2022 Q1	5/13/2022	192	0.0%	78,075	3/31/2022
2021 Q4	2/11/2022	217	0.0%	76,964	12/31/2021
2021 Q3	11/12/2021	313	0.0%	76,964	9/30/2021
2021 Q2	8/13/2021	329	0.0%	67,724	6/30/2021